Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions
- PMID: 2702777
- PMCID: PMC1542130
Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions
Abstract
Experiments were performed in Baltimore, Maryland and in Santiago, Chile, to determine the level of Salmonella typhi antigen-driven in vitro lymphocyte replication response which signifies specific acquired immunity to this bacterium and to determine the best method of data analysis and form of data presentation. Lymphocyte replication was measured as incorporation of 3H-thymidine into desoxyribonucleic acid. Data (ct/min/culture) were analyzed in raw form and following log transformation, by non-parametric and parametric statistical procedures. A preference was developed for log-transformed data and discriminant analysis. Discriminant analysis of log-transformed data revealed 3H-thymidine incorporation rates greater than 3,433 for particulate S. typhi, Ty2 antigen stimulated cultures signified acquired immunity at a sensitivity and specificity of 82.7; for soluble S. typhi O polysaccharide antigen-stimulated cultures, ct/min/culture values of greater than 1,237 signified immunity (sensitivity and specificity 70.5%).
Similar articles
-
Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.J Infect Dis. 1987 Dec;156(6):1005-9. doi: 10.1093/infdis/156.6.1005. J Infect Dis. 1987. PMID: 3680988 No abstract available.
-
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26. Vaccine. 2015. PMID: 25433216
-
Human cell mediated immunity to porins from Salmonella typhi.Scand J Infect Dis. 1993;25(1):73-80. Scand J Infect Dis. 1993. PMID: 8384733 Clinical Trial.
-
Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S15-9. doi: 10.1086/518140. Clin Infect Dis. 2007. PMID: 17582562 Review.
-
[Mechanisms of protection in the pathogenesis of the typhoid bacterial carrier state].Zh Mikrobiol Epidemiol Immunobiol. 1983 Aug;(8):98-103. Zh Mikrobiol Epidemiol Immunobiol. 1983. PMID: 6195845 Review. Russian. No abstract available.
Cited by
-
Human cell-mediated immune responses to antigenic fractions of Salmonella typhi.Immunology. 1996 Oct;89(2):262-7. doi: 10.1046/j.1365-2567.1996.d01-723.x. Immunology. 1996. PMID: 8943724 Free PMC article.
-
Immunogenicity of Salmonella typhi Ty21a vaccine for young children.Infect Immun. 1991 Nov;59(11):4291-3. doi: 10.1128/iai.59.11.4291-4293.1991. Infect Immun. 1991. PMID: 1937790 Free PMC article. Clinical Trial.
-
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.Infect Immun. 2000 Aug;68(8):4647-52. doi: 10.1128/IAI.68.8.4647-4652.2000. Infect Immun. 2000. PMID: 10899868 Free PMC article.
-
Immunology of gut mucosal vaccines.Immunol Rev. 2011 Jan;239(1):125-48. doi: 10.1111/j.1600-065X.2010.00970.x. Immunol Rev. 2011. PMID: 21198669 Free PMC article. Review.
-
Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.Front Immunol. 2014 Oct 27;5:516. doi: 10.3389/fimmu.2014.00516. eCollection 2014. Front Immunol. 2014. PMID: 25386175 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources